Levin RL - Search Results

1

Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressant.

Laughren TP, Gobburu J, Temple RJ, Unger EF, Bhattaram A, Dinh PV, Fossom L, Hung HM, Klimek V, Lee JE, Levin RL, Lindberg CY, Mathis M, Rosloff BN, Wang SJ, Wang Y, Yang P, Yu B, Zhang H, Zhang L, Zineh I. Laughren TP, et al. Among authors: levin rl. J Clin Psychiatry. 2011 Sep;72(9):1166-73. doi: 10.4088/JCP.11r06984. J Clin Psychiatry. 2011. PMID: 21951984 Review.

2

US Food and Drug Administration warning about the risk of drug reaction with eosinophilia and systemic symptoms with ziprasidone.

Chan VC, La Grenade L, Diak IL, Levin RL. Chan VC, et al. Among authors: levin rl. J Clin Psychiatry. 2015 Sep;76(9):e1138-9. doi: 10.4088/JCP.15l09921. J Clin Psychiatry. 2015. PMID: 26455682 Free article. No abstract available.

3

Chemical Leukoderma Associated with Methylphenidate Transdermal System: Data From the US Food and Drug Administration Adverse Event Reporting System.

Cheng C, La Grenade L, Diak IL, Brinker A, Levin RL. Cheng C, et al. Among authors: levin rl. J Pediatr. 2017 Jan;180:241-246. doi: 10.1016/j.jpeds.2016.09.008. Epub 2016 Oct 10. J Pediatr. 2017. PMID: 27745746 Free PMC article.

4

Liver injury associated with dimethyl fumarate in multiple sclerosis patients.

Muñoz MA, Kulick CG, Kortepeter CM, Levin RL, Avigan MI. Muñoz MA, et al. Among authors: levin rl. Mult Scler. 2017 Dec;23(14):1947-1949. doi: 10.1177/1352458516688351. Epub 2017 Jan 13. Mult Scler. 2017. PMID: 28086032

5

Examining orthorexia nervosa: Using latent profile analysis to explore potential diagnostic classification and subtypes in a non-clinical sample.

Levin RL, Mills JS, McComb SE, Rawana JS. Levin RL, et al. Appetite. 2023 Feb 1;181:106398. doi: 10.1016/j.appet.2022.106398. Epub 2022 Nov 28. Appetite. 2023. PMID: 36455786

6

Exploring two models of emotion regulation: how strategy use, abilities, and flexibility relate to well-being and mental illness.

Levin RL, Rawana JS. Levin RL, et al. Anxiety Stress Coping. 2022 Nov;35(6):623-636. doi: 10.1080/10615806.2021.2018419. Epub 2021 Dec 21. Anxiety Stress Coping. 2022. PMID: 34931928

7

Comment on: "Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs".

Suggs CM, Levin RL, Mosholder AD, Swain RS, Zhao L. Suggs CM, et al. Among authors: levin rl. Drug Saf. 2018 Dec;41(12):1419-1421. doi: 10.1007/s40264-018-0726-3. Drug Saf. 2018. PMID: 30232739 No abstract available.

8

Labeling and Drug Safety Communication Approaches to Loperamide Abuse.

Woronow D, Swank KA, Wu E, Kortepeter C, Levin RL. Woronow D, et al. Among authors: levin rl. JACC Clin Electrophysiol. 2017 Apr;3(4):422. doi: 10.1016/j.jacep.2017.02.011. Epub 2017 Apr 17. JACC Clin Electrophysiol. 2017. PMID: 29759458 Free article. No abstract available.

9

Takotsubo Common Pathways and SNRI Medications.

Woronow D, Suggs C, Levin RL, Diak IL, Kortepeter C. Woronow D, et al. Among authors: levin rl. JACC Heart Fail. 2018 Apr;6(4):347-348. doi: 10.1016/j.jchf.2017.12.011. JACC Heart Fail. 2018. PMID: 29598939 Free article. No abstract available.

10

Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse.

Swank KA, Wu E, Kortepeter C, McAninch J, Levin RL. Swank KA, et al. Among authors: levin rl. J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S63-S67. doi: 10.1016/j.japh.2016.11.011. Epub 2017 Jan 7. J Am Pharm Assoc (2003). 2017. PMID: 28073687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page